A Study to Compare Rosuvastatin/Ezetimibe and Rosuvastatin in Patients With Diabetes Mellitus and Hypercholesterolemia

A Multicenter Clinical Trial to Compare the Efficacy and Safety Between Rosuvastatin/Ezetimibe Combination and Monotherapy of Rosuvastatin in Patients With Diabetes Mellitus and Hypercholesterolemia

A Study to Compare Rosuvastatin/Ezetimibe Combination and Monotherapy in Patients with Diabetes Mellitus and Hypercholesterolemia.

This trial is conducted to compare the efficacy and safety between Rosuvastatin/Ezetimibe combination and Rosuvastatin monotherapy in patients with Diabetes Mellitus and Hypercholesterolemia for 8 weeks.

Inclusion Criteria:

• Subjects ≥ 19 or ≤ 75 years of age
• Subjects undergoing treatment for type 2 diabetes
• Subjects undergoing treatment of statin for hypercholesterolemia
• Fasting LDL-C ≤ 250mg/dL at the screening visit
• Fasting LDL-C ≥70mg/dL or ≤ 160mg/dL at the randomization visit
• Fasting TG<500mg/dL

Exclusion Criteria:

• Subjects with hypersensitivity reaction to Statin and Ezetimibe
• Subjects with severe kidney disease
• Subjects with HIV positive result at the screening
• Pregnant or breast-feeding subjects
• Subjects with taking any medication affecting level of LDL (Fenofibrate, Omega 3 fatty aicd etc.)
• Insulin-treated Subjects
• Other exclusions applied